Technetium Tc-99m tilmanocept Terminated Phase 2 Trials for Uterine Cervical Neoplasms Diagnostic

TerminatedDiagnostic2 IdentifierTitleDrugs
NCT02509585A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection